Recruiting
ASMact: Study on Management of Bronchial Asthma
Standardization According to GINA 2025 Recommendations for the Treatment, Management, and Follow-up of Acute Asthma Attacks: Observational, Multicenter Cohort Study.
ClinicalTrials.gov IDNCT07412769
PhaseNot Applicable
Enrollment500
SponsorMeyer Children's Hospital IRCCS
Age6 Years
SexALL
Conditions studied
Asthma Acute, Asthma Childhood, Asthma in Children, Asthma Crisis
About this study
Standardization According to GINA 2025 Recommendations for the Treatment, Management, and Follow-up of Acute Asthma Attacks: Observational, Multicenter Cohort Study.
Primary outcomes
- Change in the number of correctly reported diagnoses before and after intervention (Pre-intervention and through study completion, an average of 9 months)
- Percentage of patients with correct timing, dosage, and method of drug administration before and after intervention (Pre-intervention and through study completion, an average of 9 months)
- Percentage of patients with correct follow-up at discharge (Pre-intervention and through study completion, an average of 9 months)
- Percentage of patients in whom additional drugs are used in refractory cases (Pre-intervention and through study completion, an average of 9 months)
- Percentage of patients with correct therapy at discharge (Pre-intervention and through study completion, an average of 9 months)
Eligibility information
Inclusion Criteria:
* Age between 6 and 17 years
* Presentation to the emergency department with a diagnosis of acute asthma exacerbation
* Evaluation in the emergency department of one of the participating centers during the study periods
Exclusion Criteria:
* Age \< 6 years or \> 17 years
* Diagnosis other than acute asthma exacerbation
* Incomplete or missing clinical data
* Patients transferred from other hospitals already treated for the same episode
* history of allergy to any drugs used in the protocol
Study locations
- Arcispedale S. Anna, Ferrara, FE 44124 Italy
- Meyer Children's Hospital IRCCS, Firenze, Florence, 50134 Italy
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.